CSPC PHARMACEUT.GR. ADR4 (CVGU) — Financial Flexibility Index

Latest as of December 2025: 0.67x

CSPC PHARMACEUT.GR. ADR4 (CVGU) has a Financial Flexibility Index of 0.67x as of December 2025. Free cash flow of €8.11 Billion (operating CF €5.83 Billion minus capex €2.28 Billion) represents 1% of total liabilities (€12.15 Billion). Check CSPC PHARMACEUT.GR. ADR4 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Financial Flexibility Index

0.67x
Free Cash Flow / Total Liabilities

Free Cash Flow

€8.11 Billion
Operating CF − Capex

Total Liabilities

€12.15 Billion
EUR

Capital Expenditures

€2.28 Billion
EUR

CSPC PHARMACEUT.GR. ADR4 Financial Flexibility Index (2021–2025)

Historical Financial Flexibility Index trend for CSPC PHARMACEUT.GR. ADR4 across 5 annual periods. For the full cash flow conversion analysis, see CVGU operating cash flow.

Annual Financial Flexibility Index for CSPC PHARMACEUT.GR. ADR4 (2021–2025)

Year-by-year free cash flow to debt coverage for CSPC PHARMACEUT.GR. ADR4. Explore how well can CSPC PHARMACEUT.GR. ADR4 service its debt to assess how comfortably operating cash covers total debt obligations.

Year Flexibility Index Free Cash Flow (EUR) Operating CF Total Liabilities YoY Change
2025 0.67x €8.11 Billion €5.83 Billion €12.15 Billion ▼ -2.6%
2024 0.69x €7.21 Billion €4.53 Billion €10.52 Billion ▲ +27.2%
2023 0.54x €6.07 Billion €4.18 Billion €11.26 Billion ▼ -47.3%
2022 1.02x €10.35 Billion €7.63 Billion €10.13 Billion ▲ +26.5%
2021 0.81x €6.40 Billion €4.64 Billion €7.91 Billion
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities